Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Titel:
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
Auteur:
Illerhaus, Gerald Ferreri, Andrés J.M. Binder, Mascha Borchmann, Peter Hasenkamp, Justin Stilgenbauer, Stephan Roeth, Alexander Weber, Thomas Egerer, Gerlinde Ernst, Thomas Hertenstein, Bernd Lenz, Georg Kobbe, Guido Brunnberg, Uta Schmidt, Christian Kneba, Michael Dreyling, Martin Möhle, Robert Panse, Jens Heinicke, Thomas Schroll, Sebastian Larsen, Thomas S. Salwender, Hans Naumann, Ralph Hess, Georg Thurner, Lorenz Pukrop, Tobias Keller, Ulrich Blystadt, Anne Kirsti Kroschinsky, Frank P. Re, Francesca Pulczynski, Elisa Orsucci, Lorella Pospiech, Lisa Deckert, Martina Ponzoni, Maurilio Wendler, Julia Valk, Elke Calimeri, Teresa Kasenda, Benjamin Trepel, Martin Fricker, Heidi von Gottberg, Philipp Burger, Elvira Ihorst, Gabriele Grishina, Olga Hader, Claudia Zucca, Emanuele Finke, Jürgen Schorb, Elisabeth